nach oben

Erschienen in:

2015 | OriginalPaper | Buchkapitel

13. Polymers in Nephrology

verfasst von : Jörg Vienken, Oliver Gottschalk

Erschienen in: Advanced Polymers in Medicine

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The use of polymers in nephrology represents a success story. Their selection, chemical modification and application in medical devices applied to hemodialysis (HD) and peritoneal dialysis (PD) allows for the successful treatment of more than 2.5 million dialysis patients worldwide in 2013 (HD: 2,250,000; PD: 272,000). Properties of polymer families applied for the production of membranes, tubing, PD-bags and filter housing material refer to performance, sterilization and blood compatibility. For all polymers, including those for housings and tubing, the amount of leachables has currently received increasing interest. It can be explained by the notion that treatment durations increase and the number of elderly patients with an impaired immune system is on the rise. New developments and selection of new polymers should target unspecific adsorption characteristics and interactive systems.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Drug Delivery Systems: Smart Polymeric Materials

Nächstes Kapitel Polymers in Wound Repair

Abel, J., Rowntree, L., Turner, B.: On the removal of diffusible substances from the circulating blood of living animals by means of dialysis. J. Pharmacol. Exp. Ther. 5, 275–283 (1913)

Haas, G.: Dialysieren des strömenden Bluts am Lebenden. Klin Wochenschr 2, 1888 (1923)CrossRef

Haas, G.: Die Methodik der Blutauswaschung (Dialysis in vivo). In: Abderhalden, E (ed.) Handbuch der biologischen Arbeitsmethoden, Abt V, pp. 717–754. Urban-Schwarzenberg, Berlin/Wien (1935)

Nakai, S., Watanabe, Y., Masakane, I., Wada, A., Shoji, T., Hasegawa, T., Nakamoto, H., Yamagata, K., Kazama, K., Fujii, N., Itami, N., Shinoda, T., Shigematsu, T., Marubayashi, S., Morita, O., Hashimoto, S., Suzuki, K., Kimata, N., Hanafusa, N., Wakai, K., Hamano, T., Ogata, S., Tsuchida, K., Taniguchi, M., Nishi, H., Iseki, K., Tsubakihara, Y.: Overview of regular dialysis treatment in Japan (as of 31 December 2011). Ther. Apher. Dial. 17, 567–611 (2013)CrossRef

Knauf, F., Aronson, P.: ESRD as a window into America’s cost crisis in health care. J. Am. Soc. Nephrol. 20, 2093–2097 (2009)CrossRef

Henderson, L., Chenoweth, D.: Cellulose membranes–time for a change? Contrib. Nephrol. 44, 112–126 (1985)

Canaud, B., Bragg-Gresham, J., Marshall, M., Desmeules, S., Gillespie, B., Depner, T., Klassen, P., Port, F.: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 69, 2087–2093 (2006)CrossRef

Maduell, F., Moreso, F., Pons, M., Ramos, R., Mora-Macia, J., Carreras, J., Soler, J., Torres, F., Campistol, J., Martinez-Castellao, A.: High efficiency postdilutional online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J. Am. Soc. Nephrol. 24, 487–497 (2013)CrossRef

Klinkmann, H., Falkenhagen, D., Stefoni, S., Bonomini, V.: Biocompatibility, the need for a systems approach. Contrib. Nephrol. 70, 213–226 (1989)

10.

Kiil, F.: Development of a parallel-flow artificial kidney in plastics. Acta Chir. Scand. Suppl. 253(Suppl), 142–150 (1960)

11.

Stewart, R., Cerny, J., Lipps, B., Holmes, G.: Hemodialysis with the capillary kidney. Univ. Mich. Med. Cent. J. 34, 80–83 (1968)

12.

Kuelz, M., Nederlof, B., Schneider, H.: In vitro and in vivo evaluation of a new dialyzer. Nephrol. Dial. Transplant. 17, 1475–1479 (2002)CrossRef

13.

Gong, H., Zhang, X., Cheng, B., Sun, Y., Li, C., Li, T., Zheng, L., Huang, K.: Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between Bisphenol A exposure and type 2 diabetes. PLoS ONE 8, 54198 (2013)CrossRef

14.

Kanno, Y., Okada, H., Kobayashi, T., Takenaka, T., Suzuki, H.: Effects of endocrine disrupting substance on estrogen receptor gene transcription in dialysis patients. Ther. Apher. Dial. 11, 262–265 (2007)CrossRef

15.

Buteau, H., Velasco, G., Cristofari, M., Balaguer, P., Perrot-Applanat, M.: Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J. Endocrinol. 196, 399–412 (2008)CrossRef

16.

Krieter, D., Canaud, B., Lemke, H.D., Rodriguez, A., Morgenroth, A., von Appen, K., Dargoun, G.P., Wanner, C.: Bisphenol A in chronic kidney disease. Artif. Organs 37, 283–290 (2012)CrossRef

17.

Tee, R., Cullinan, P., Welch, J., Burge, P.S., Newman-Taylor, A.: Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101, 709–715 (1998)CrossRef

18.

Röckel, A., Klinke, B., Hertel, J., Baur, X., Thiel, C., Abdelhamid, S., Fiegel, P., Walb, D.: Allergy to dialysis materials. Nephrol. Dial. Transplant. 4, 646–652 (1989)

19.

Skarping, G., Dalene, M., Littorin, M.: 4,4′-Methylenedianiline in hydrolysed serum and urine from a worker exposed to thermal degradation products of methylene diphenyl di-isocyanate elastomers. Int. Arch. Occup. Environ. Health 67, 73–77 (1995)CrossRef

20.

Bowry, S., Gatti, E., Vienken, J.: Contribution of polysulfone membranes to the success of convective therapies. Contrib. Nephrol. 173, 110–118 (2011)CrossRef

21.

Fresenius Medical Care (2014) ESRD Patients, a global perspective Company Brochure

22.

Streicher, E., Schneider, H.: Polysulphone membrane mimicking human glomerular basement membrane. Lancet 322, 1136 (1983)CrossRef

23.

Kerr, P., Huang, L.: Membranes for hemodialysis. Nephrology 15, 381–385 (2010)CrossRef

24.

Matsuda, T.: Biological responses at non-physiological interfaces and molecular design of biocompatible surfaces. Nephrol. Dial. Transplant. 4(Suppl. 3), 60–66 (1988)

25.

Schindler, R.: Inflammation and dialysate quality. Hemodial. Int. 10, S56–S59 (2006)CrossRef

26.

Lonnemann, G.: Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif. 18, 214–223 (2000)CrossRef

27.

Hayama, M., Miyasaka, T., Mochizuki, S., Asahara, H., Tsujioka, K., Kohori, F., Sakai, K., Jinbo, Y., Yoshida, M.: Visualisation of distribution of endotoxin trapped in an endotoxin-blocking filtration membrane. J. Membr. Sci. 210, 45–53 (2002)CrossRef

28.

Nakatani, T., Tsuchida, K., Sugimura, K., Yoshimura, R., Takemoto, Y.: Investigation of endotoxin adsorption with polyether polymer alloy dialysis membranes. Int. J. Mol. Med. 11, 195–197 (2003)

29.

Henrie, M., Ford, C., Andersen, M., Stroup, E., Diaz-Buxo, J., Madsen, B., Britt, D., Ho, C.: In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology and permeability. Artif. Organs 32, 701–710 (2008)CrossRef

30.

Weber, V., Linsberger, I., Rossmanith, E., Weber, C., Falkenhagen, D.: Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif. Organs 28, 210–217 (2004)CrossRef

31.

Thomas, M., Moriyama, K., Ledebo, I.: AN69: Evolution of the world’s first high permeability membrane. Contrib. Nephrol. 173, 119–129 (2011)CrossRef

32.

Valette, P., Thomas, M., Déjardin, P.: Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and simulations. Biomaterials 20, 1621–1634 (1999)CrossRef

33.

Moachon, N., Boullanger, C., Fraud, S., Vial, E., Thomas, M., Quash, G.: Influence of the charge of low molecular weight proteins on their efficacy of filtration and/or adsorption on dialysis membranes with different intrinsic properties. Biomaterials 23, 651–658 (2002)CrossRef

34.

Pascual, M., Schifferli, J.A.: Adsorption of complement factor D by polyacrylonitrile membranes. Kidney Int. 43, 903–911 (1993)CrossRef

35.

Mori, H., Hiraoka, K., Yorifuji, R., Iwasaki, T., Gomikawa, S., Inagaki, O., Inoue, S., Takamitsu, Y., Fujita, Y.: Adsorption of human recombinant erythropoietin on dialysis membranes in vitro. Artif. Organs 18, 725–728 (1994)CrossRef

36.

Cheung, A.K., Hohnholt, M., Leypoldt, J.K., DeSpain, M.: Hemodialysis membrane biocompatibility: the case of erythropoietin. Blood Purif. 9, 153–163 (1991)CrossRef

37.

Opatrny Jr, K., Krouzecky, A., Wirth, J., Vit, L., Eiselt, J.: The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis. Artif. Organs 22, 816–820 (1998)CrossRef

38.

Groth, T., Synowitz, J., Malsch, G., Richau, K., Albrecht, W., Lange, K.-P., Paul, D.: Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein heparinized plasma. J. Biomat. Sci. Polmer Edn. 8, 797–807 (1997)CrossRef

39.

Rollason, G., Sefton, M.: Measurement of the rate of thrombin production in human plasma in contact with different materials. J. Biomed. Mat. Res. 26, 675–693 (1992)CrossRef

40.

Vogler, E., Siedlecki, C.: Contact activation of blood-plasma coagulation. Biomaterials 30, 1857–1869 (2009)CrossRef

41.

Sperling, C., Fischer, M., Maitz, M., Werner, C.: Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials 30, 4447–4456 (2009)CrossRef

42.

Verresen, L., Waer, M., Vanrenterghem, Y., Michielsen, P.: Angiotensin-converting-enzyme-inhibitors and anaphylactic reactions to high-flux membrane dialysis. Lancet 336, 1360–1362 (1990)CrossRef

43.

Tielemans, C., Madhoun, P., Lenaers, M., Schandene, L., Goldman, M., Vanherweghem, J.L.: Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int. 38, 982–984 (1990)CrossRef

44.

Parnes, E.L., Shapiro, W.B.: Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer. Kidney Int. 40, 1148–1152 (1991)CrossRef

45.

Brunet, P., Jaber, K., Berland, Y., Baz, M.: Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I converting enzyme inhibitors. Am. J. Kidney Dis. 9, 444–447 (1992)CrossRef

46.

Krieter, D., Grude, M., Lemke, H.D., Fink, E., Bönner, G., Schölkens, B., Schulz, E., Müller, G.A.: Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int. 53, 1026–1035 (1998)CrossRef

47.

Brophy, P., Mottes, T., Kudelka, T., McBryde, K., Gradner, J., Maxvold, N., Bunchman, T.: AN-69 membrane reactions are pH-dependent and preventable. Am. J. Kidney Dis. 38, 173–178 (2001)CrossRef

48.

Renaux, J., Thomas, M., Crost, T., Loughraieb, N., Vantard, G.: Activation of the kalikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution and pH. Kidney Int. 55, 1097–1103 (1999)CrossRef

49.

Shiba, M., Tadokoro, K., Sawanobori, M., Nakajima, K., Suzuki, K., Juji, T.: Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 37, 457–462 (1997)CrossRef

50.

Krieter, D.H., Steinke, J., Kerkhoff, M., Fink, E., Lemke, H.D., Zingler, C., Müller, G.A., Schuff-Werner, P.: Contact activation in low-density lipoprotein apheresis systems. Artif. Organs 29, 47–52 (2005)CrossRef

51.

Adam, A., Montpas, N., Keire, D., Désormeaux, A., Brown, N.J., Marceau, F., Westenberger, B.: Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro. Biomaterials 31, 5741–5748 (2010)CrossRef

52.

Désormeaux, Al, Moreau, M.E., Lepage, Y., Chanard, J., Adam, A.: The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 29, 1139–1146 (2008)CrossRef

53.

Gretz, N., Bowry, S., Vienken, J., Odenwälder, W., Strauch, M.: Simple approach to heparin-free dialysis. Nephrol. Dial. Transplant. 8, 990 (1993)

54.

Lavaud, S., Paris, B., Maheut, H., Randoux, C., Renaux, J.L., Rieu, P., Chanard, J.: Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration. ASAIO J. 51, 348–351 (2005)CrossRef

55.

Kessler, M., Gangemi, C., Gutierrez Martones, A., Lacombe, J., Krier-Coudert, M., Galland, R., Kielstein, J., Moureau, F., Loughraieb, N.: Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study. Hemodial. Int. 17, 282–293 (2013)CrossRef

56.

Sugaya, H., Sakai, Y.: Polymethylmethacrylate: from polymer to dialyzer. Contrib. Nephrol. 125, 1–8 (1998)CrossRef

57.

Fabbrini, P., Sirtori, S., Casiraghi, E., Pieruzzi, F., Genovesi, S., Corti, D., Brivio, R., Gregorini, G., Como, G., Carati, M., Vignano, M., Stella, A.: Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties. Blood Purif. 35(Suppl 2), 52–58 (2013)CrossRef

58.

Locatelli, F., Andrulli, S., Pecchini, F., Pedrini, L., Agliata, S., Lucchi, L., Farina, M., La Milia, V., Grassi, C., Borghi, M.: Effect of high-flux dialysis on the anemia of haemodialysis patients. Nephrol. Dial. Transplant. 15, 1399–1409 (2000)CrossRef

59.

Goeksel, T., Xie, W., Ritzerfeld, M., Heidenreich, S., Mann, H.: Prurigo nodularis and dialyzer membrane. Blood Purif. 35(Suppl 2), 26–27 (2013)CrossRef

60.

Narita, I., Aichi, B., Omori, K., Sato, F., Ajiro, J., Saga, D., Kondo, D., Skatsume, M., Maruyama, S., Kazama, J., Akazawa, K., Gejyo, F.: The effect of polymethylmethacrylate dialysis membranes on uremic pruritus. Kidney Int. 69, 1626–1632 (2006)CrossRef

61.

Schwarzbeck, A., Wittenmeier, K.-W., Hällfritzsch, U., Frank, J.: Anaphylactoid reactions ACE inhibitors and extracorporeal hemotherapy. Nephron 65, 499–500 (1993)CrossRef

62.

Nakano, A.: Ethylene vinyl alcohol co-polymer as a high-performance membrane. An EVOH membrane with excellent biocompatibility. Contrib. Nephrol. 173, 164–171 (2011)CrossRef

63.

Sirolli, V., Ballone, E., Di Stante, S., Amoroso, I., Bonomini, M.: Cell activation and cellular-cellular interactions during hemodialysis. Int. J. Artif. Organs 25, 529–537 (2002)

64.

Ito, S., Suzuki, C., Tsuji, S.: Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J. Biomed. Mater. Res. 77A, 294–303 (2006)CrossRef

65.

Ivanovich, P., Chenoweth, D., Schmidt, R., Klinkmann, H., Boxer, L., Jacob, H., Hammerschmidt, D.: Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int. 24, 758–763 (1983)CrossRef

66.

Urbani, A., Louisell, S., Sirolli, V., Bucci, S., Amoroso, L., Pavone, B., Pieroni, L., Sacchetta, P., Bonomini, M.: Proteomic analysis of protein adsorption capacity of different haemodialysis membranes. Mol. BioSyst. 8, 1029–1039 (2012)CrossRef

67.

Averbukh, Z., Modai, D., Sandbank, J., Berman, S., Cohn, M., Galperin, E., Cohen, N., Dishi, V., Weissgarten, J.: Red eye syndrome: clinical and experimental experience in a new aspect of diffusive eosinophilic infiltration? Artif. Organs 25, 437–440 (2001)CrossRef

68.

Sunohara, T., Masuda, T.: Cellulose triacetate as a high-performance membrane. Contrib. Nephrol. 173, 156–163 (2011)CrossRef

69.

Ronco, C., Tetta, C.: Extracorporeal blood purification: more than diffusion and convection. Does this help? Curr. Opin. Care 13, 662–667 (2007)CrossRef

70.

Ronco, C.: Sorbents; from bench to bedside. Can we combine membrane separation processes and adsorbent based solute removal? Int. J. Artif. Organs 29, 819–822 (2006)

71.

Bouman, C., van Olden, R., Stoutenbeek, C.: Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif. 16, 261–268 (1998)CrossRef

72.

Vanholder, R., de Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., de Deyn, P., Deppisch, R., Descamps-Latscha, B., Henle, T., Jörres, A., Lemke, H.D., Massy, Z., Passlick-Deetjen, J., Rodriguez, M., Stegmayr, B., Stenvinkel, P., Tetta, C., Wanner, C., Zidek, W.: Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 63, 1934–1963 (2003)CrossRef

73.

Klammt, S., Wojak, H., Mitzner, A., Koball, S., Rychly, J., Reisinger, E., Mitzner, S.: Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins. Nephrol. Dial. Transplant. 27, 2372–2383 (2012)CrossRef

74.

Varshney, A., Rehan, M., Subbarao, N., Rabbani, G., Khan, R.: Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding. PLoS ONE 6, 17230 (2011)CrossRef

75.

Henne, W., Pohle, R., Lawitzki, F.: Dialysis membrane for hemodialysis. German Patent 2705734 C3 (1978)

76.

Tijink, M., Kooman, J., Wester, M., Sun, J., Saiful, S., Joles, J., Borneman, Z., Wessling, M., Stamatialis, D.: Mixed matrix membranes: a new asset for blood purification therapies. Blood Purif. 37, 1–3 (2014)CrossRef

77.

Weissinger, E., Kaiser, T., Meert, N., deSmet, R., Walden, M., Mischak, H., Vanholder, R.: Proteomics: a novel tool to unravel the patho-physiology of uraemia. Nephrol. Dial. Transplant. 19, 3068–3077 (2004)CrossRef

78.

Maduell, F., Arias-Guillen, M., Fontseré, N., Ojeda, R., Rico, N., Vera, M., Elena, M., Bedini, J., Wienecke, P., Campistol, J.: Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif. 37, 125–130 (2014)CrossRef

79.

Lamy, T., Henri, P., Lobbedez, T., Comby, E., Ryckelynck, J., Ficheux, M.: Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polycloncal free light chain removal. Blood Purif. 37, 93–98 (2014)CrossRef

Titel: Polymers in Nephrology
verfasst von: Jörg Vienken
Oliver Gottschalk
Verlag: Springer International Publishing
Buch: Advanced Polymers in Medicine
Print ISBN: 978-3-319-12477-3

Electronic ISBN: 978-3-319-12478-0

Copyright-Jahr: 2015
DOI: https://doi.org/10.1007/978-3-319-12478-0_13

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht